公开(公告)号：WO2007064978A2

公开(公告)日：2007-06-07

申请号：PCT/US2006/046159

申请日：2006-11-30

Applicant: CELATOR PHARMACEUTICALLS, INC. ,  MAYER, Lawrence

Inventor： MAYER, Lawrence

IPC: A61F2/02

CPC classification number: A61L31/16 ,  A61L31/10 ,  A61L2300/61

Abstract: Implants comprising controlled delivery matrices, associated with, or including medical devices, having stably and releasably associated therewith predetermined non- antagonistic combinations of two or more therapeutic agents provide control of the ratio of these agents at a localized site. Methods of identifying such combinations are also disclosed.

Abstract translation: 包含受控递送基质的植入物，与或具有医疗装置相关联或包含医疗装置的植入物，其具有稳定和可释放地与两种或更多种治疗剂的预定非拮抗性组合相关联，提供了这些药剂在局部位点处的比率的控制。 还公开了鉴定这种组合的方法。

公开(公告)号：WO2007064978A3

公开(公告)日：2007-12-27

申请号：PCT/US2006046159

申请日：2006-11-30

Applicant: CELATOR PHARMACEUTICALLS INC ,  MAYER LAWRENCE

Inventor： MAYER LAWRENCE

IPC: A61K31/00 ,  A61K31/13 ,  A61K31/22 ,  A61K31/275

CPC classification number: A61L31/16 ,  A61L31/10 ,  A61L2300/61

Abstract: Implants comprising controlled delivery matrices, associated with, or including medical devices, having stably and releasably associated therewith predetermined non- antagonistic combinations of two or more therapeutic agents provide control of the ratio of these agents at a localized site. Methods of identifying such combinations are also disclosed.

Abstract translation: 包含受控递送基质，与或与其包含医疗装置的植入物具有稳定且可释放地与两种或更多种治疗剂的预定非拮抗组合相关联，从而提供对这些试剂在局部位置处的比率的控制。 还公开了识别这种组合的方法。